Free Trial
NASDAQ:CLBT

Cellebrite DI (CLBT) Stock Price, News & Analysis

Cellebrite DI logo
$19.00 +0.24 (+1.28%)
(As of 11/20/2024 ET)

About Cellebrite DI Stock (NASDAQ:CLBT)

Key Stats

Today's Range
$18.72
$19.26
50-Day Range
$16.52
$19.15
52-Week Range
$7.91
$21.00
Volume
2.05 million shs
Average Volume
1.49 million shs
Market Capitalization
$3.91 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$20.29
Consensus Rating
Buy

Company Overview

Cellebrite DI Ltd. develops solutions for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company's DI suite of solutions allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations used in various cases, including child exploitation, homicide, anti-terror, border control, sexual crimes, human trafficking, corporate security, cryptocurrency, and intellectual property theft. It provides Inseyets, a digital forensics software that collects and reviews digital evidence from various digital sources when conducting legally sanctioned investigations. The company's digital forensics software also offers data extraction, decoding capabilities, workflows, and automation capabilities. In addition, it provides Cellebrite Pathfinder, which reduces the time spent manually reviewing digital evidence by automating data analysis and visualization; Smart Search, an open source intelligence tool that automates the collection and review of publicly available online data; and Guardian, a case and evidence management solution. Further, the company offers digital forensic software for enterprises and service providers, including Inseyets for Enterprise, Endpoint Inspector, and Mobile Now; and professional services, such as training and certification services, and other services. It serves federal and state and local agencies. The company was incorporated in 1999 and is headquartered in Petah Tikva, Israel.

Cellebrite DI Stock Analysis - MarketRank™

See Top Rated MarketRank™ Stocks
17th Percentile Overall Score

CLBT MarketRank™: 

Cellebrite DI scored higher than 17% of companies evaluated by MarketBeat, and ranked 302nd out of 328 stocks in the business services sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Cellebrite DI has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 8 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Cellebrite DI has only been the subject of 4 research reports in the past 90 days.

  • Read more about Cellebrite DI's stock forecast and price target.
  • Earnings Growth

    Earnings for Cellebrite DI are expected to decrease by -6.25% in the coming year, from $0.32 to $0.30 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Cellebrite DI is -12.26, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Cellebrite DI is -12.26, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Growth Ratio

    Cellebrite DI has a PEG Ratio of 2.55. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Cellebrite DI has a P/B Ratio of 13.10. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Cellebrite DI's valuation and earnings.
  • Percentage of Shares Shorted

    1.83% of the float of Cellebrite DI has been sold short.
  • Short Interest Ratio / Days to Cover

    Cellebrite DI has a short interest ratio ("days to cover") of 1.1, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Cellebrite DI has recently increased by 5.59%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Cellebrite DI does not currently pay a dividend.

  • Dividend Growth

    Cellebrite DI does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    1.83% of the float of Cellebrite DI has been sold short.
  • Short Interest Ratio / Days to Cover

    Cellebrite DI has a short interest ratio ("days to cover") of 1.1, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Cellebrite DI has recently increased by 5.59%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    Cellebrite DI has a news sentiment score of 0.67. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.54 average news sentiment score of Business Services companies.
  • News Coverage This Week

    MarketBeat has tracked 7 news articles for Cellebrite DI this week, compared to 4 articles on an average week.
  • Search Interest

    7 people have searched for CLBT on MarketBeat in the last 30 days. This is an increase of 17% compared to the previous 30 days.
  • MarketBeat Follows

    Only 5 people have added Cellebrite DI to their MarketBeat watchlist in the last 30 days. This is a decrease of -17% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Cellebrite DI insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 5.70% of the stock of Cellebrite DI is held by insiders.

  • Percentage Held by Institutions

    45.88% of the stock of Cellebrite DI is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Cellebrite DI's insider trading history.
Receive CLBT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cellebrite DI and its competitors with MarketBeat's FREE daily newsletter.

CLBT Stock News Headlines

Cellebrite, Relativity deliver solutions to transform mobile data collection
Bill Gates’s Next Big AI Bet: Stargate
In February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of my favorite stocks. Shares have jumped by more than 20,000% since then.
See More Headlines

CLBT Stock Analysis - Frequently Asked Questions

Cellebrite DI's stock was trading at $8.66 at the start of the year. Since then, CLBT shares have increased by 119.4% and is now trading at $19.00.
View the best growth stocks for 2024 here
.

Cellebrite DI Ltd. (NASDAQ:CLBT) released its earnings results on Wednesday, November, 6th. The company reported $0.14 earnings per share for the quarter, beating the consensus estimate of $0.09 by $0.05. Cellebrite DI's revenue for the quarter was up 27.0% on a year-over-year basis.

Cellebrite DI's top institutional shareholders include FMR LLC (2.73%), Clal Insurance Enterprises Holdings Ltd (1.93%), Meitav Investment House Ltd. (1.00%) and Pembroke Management LTD (0.93%).

Shares of CLBT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that Cellebrite DI investors own include Humana (HUM), American Water Works (AWK), Voyager Therapeutics (VYGR), Waste Connections (WCN), The RMR Group (RMR), TotalEnergies (TTE) and Southern First Bancshares (SFST).

Company Calendar

Last Earnings
11/06/2024
Today
11/20/2024
Fiscal Year End
12/31/2024
Next Earnings (Estimated)
2/20/2025

Industry, Sector and Symbol

Industry
Prepackaged software
Sub-Industry
Computer Software
Current Symbol
NASDAQ:CLBT
Employees
1,008
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$20.29
High Stock Price Target
$24.00
Low Stock Price Target
$17.00
Potential Upside/Downside
+6.8%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
8 Analysts

Profitability

Net Income
$-81,100,000.00
Pretax Margin
-80.02%

Debt

Sales & Book Value

Annual Sales
$385.17 million
Cash Flow
$0.29 per share
Book Value
$0.18 per share

Miscellaneous

Free Float
194,194,000
Market Cap
$3.91 billion
Optionable
Optionable
Beta
1.50
A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report

This page (NASDAQ:CLBT) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners